ICD-10 Coding for Nasopharyngeal Carcinoma(B97.2U, C11.0, C11.0B)
Comprehensive guide to ICD-10 coding for nasopharyngeal carcinoma, including specific codes, documentation requirements, and coding pitfalls.
Complete code families applicable to Nasopharyngeal Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C11.0 | Malignant neoplasm of superior wall of nasopharynx | Use when the tumor is confirmed to be located at the superior wall of the nasopharynx. |
|
| C11.9 | Malignant neoplasm of nasopharynx, unspecified | Use when the specific location within the nasopharynx is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNasopharyngeal Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Nasopharyngeal Carcinoma.
Failure to document EBV status
Impact
Clinical: May affect treatment decisions and prognosis., Regulatory: Non-compliance with documentation standards., Financial: Potential for reduced reimbursement if coding is incomplete.
Mitigation
Ensure EBV testing is ordered and results documented, Include EBV status in all relevant clinical notes
Using C11.9 when a more specific code is available
Impact
Reimbursement: May result in lower reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines for specificity., Data Quality: Reduces the quality of clinical data for research and treatment planning.
Mitigation
Ensure documentation specifies the exact tumor location within the nasopharynx.
Specificity of tumor location coding
Impact
Audits may focus on whether the most specific code was used based on documentation.
Mitigation
Train staff on importance of documenting precise tumor locations.